Methods: The goal of this review was to analyze the post-vaccination adverse effects associated with Live Attenuated Influenza Vaccine (LAIV) compared to those of the Injectable Trivalent Inactivated Vaccine (TIV) in patients with egg allergy and asthma. PubMed, Ovid, and Google searches were conducted. Searched articles relating to allergic reactions, asthma or food allergy, and LAIV were reviewed.
Results: Similar or superior efficacy of LAIV compared to TIV was reported by various studies. Respiratory symptoms were the most common adverse events following both vaccinations. Although no evidence was found of a direct causal relationship between intranasal influenza vaccine and anaphylaxis due to egg allergy, a number of cases of anaphylaxis were reported. To date, there are no studies directly comparing the frequency of anaphylactic reactions between the two vaccines.
Conclusions: The safety of LAIV in individuals with unstable asthma and egg allergy has not been established and it should be avoided in these populations. For patients with unstable asthma, TIV should remain the therapy of choice.
Belshe, R.B., Edwards, K.M., Vesikari, T., Black, S.V., Walker, R.E., Hultquist, M. et al. (2007) Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med356(7): 685-696.
2.
Block, S.L. (2004) Role of influenza vaccine for healthy children in the US. Paediatr Drugs6(4): 199-209.
3.
Flumist® (Influenza Virus Vaccine Live, I-FMV, Inc.Product/prescribing information as of May, 2006. (Original licensure: June 17, 2003).
4.
Izurieta, H.S., Haber, P., Wise, R.P., Iskander, J., Pratt, D., Mink, C. et al. (2005) Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA294(21): 2720-2725.
5.
Jacobson, R.M. and Poland, G.A. (2002) Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine. Paediatr Drugs4(1): 65-71.
6.
Nichol, K.L., Mendelman, P.M., Mallon, K.P., Jackson, L.A., Gorse, G.J., Belshe, R.B. et al. (1999) Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA282(2): 137-144.
7.
Smith, N.M., Bresee, J.S. and Shay, D.K. (2006) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(RR-10): 1-42.
8.
Zangwill, K.M. and Belshe, R.B. (2004) Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination . Pediatr Infect Dis J23(3): 189-197.
